Paxlovid-associated dysgeusia
- PMID: 35830268
- DOI: 10.1111/odi.14312
Paxlovid-associated dysgeusia
References
REFERENCES
-
- European Medicines Agency. (2021). EMA issues advice on use of Paxlovid (PF-07321332 and ritonavir) for the treatment of COVID-19: Rolling review starts in parallel. https://www.ema.europa.eu/en/news/ema-issues-advice-use-paxlovid-pf-0732...
-
- FDA. (2021). News release. Coronavirus (COVID-19) update: FDA authorizes first oral antiviral for treatment of COVID-19. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19...
-
- Hammond, J., Leister-Tebbe, H., Gardner, A., Abreu, P., Bao, W., Wisemandle, W., Baniecki, M., Hendrick, V. M., Damle, B., Simón-Campos, A., Pypstra, R., Rusnak, J. M., & EPIC-HR Investigators. (2022). Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. The New England Journal of Medicine, 386(15), 1397-1408. https://doi.org/10.1056/NEJMoa2118542
-
- Hellewell, S. (2022). The conversation. COVID made things taste weird, now ‘Paxlovid mouth’ sounds disgusting. What causes dysgeusia? https://theconversation.com/covid-made-things-taste-weird-now-paxlovid-m...
-
- Kimball, S. (2022). Paxlovid prescriptions to treat Covid increased tenfold in U.S. since late February, Pfizer says. CNBC. https://www.cnbc.com/2022/05/03/pfizer-paxlovid-prescriptions-to-treat-c...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources